Joseph M Patti
CIK 1283215 · CEO · last filed 2026-03-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INHX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
LOS ANGELES, CA 90066
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARMP | Director | — | $3.64 | — | $0 | 8 | 2026-03-11 |
| AVIR | CEO | — | $4.04 | — | $0 | 2 | 2017-04-05 |
| Vaxart, Inc. (BOTA) Delisted | CEO | 126,128 | — | — | $83.6K | 7 | 2015-09-28 |
| INHIBITEX, INC. (INHX) Delisted | Chief Scientific Officer | 0 | — | — | -$1.64M | 10 | 2011-11-08 |
Recent Filings · Page 2 of 3
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-09-28 | Vaxart, Inc. (BOTA) Delisted | Buy (P) | +5,000 | $9.3K | EDGAR |
| 2015-08-13 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-31 | Vaxart, Inc. (BOTA) Delisted | Buy (P) | +20,000 | $45.7K | EDGAR |
| 2014-10-02 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-02 | Vaxart, Inc. (BOTA) Delisted | Buy (P) | +10,000 | $28.6K | EDGAR |
| 2013-12-09 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-11-14 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | +71,661 | $0 | EDGAR |
| 2012-02-15 | — | Disp (D) | — | $0 | |
| 2011-11-08 | INHIBITEX, INC. (INHX) Delisted | Mixed | −209,596 | -$1.64M | EDGAR |
| 2011-09-16 | INHIBITEX, INC. (INHX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.